168 related articles for article (PubMed ID: 27832415)
1. Household financial burden of phenylketonuria and its impact on treatment in China: a cross-sectional study.
Wang L; Zou H; Ye F; Wang K; Li X; Chen Z; Chen J; Han B; Yu W; He C; Shen M
J Inherit Metab Dis; 2017 May; 40(3):369-376. PubMed ID: 27832415
[TBL] [Abstract][Full Text] [Related]
2. The time consuming nature of phenylketonuria: a cross-sectional study investigating time burden and costs of phenylketonuria in the Netherlands.
Eijgelshoven I; Demirdas S; Smith TA; van Loon JM; Latour S; Bosch AM
Mol Genet Metab; 2013 Jul; 109(3):237-42. PubMed ID: 23731533
[TBL] [Abstract][Full Text] [Related]
3. The personal burden for caregivers of children with phenylketonuria: A cross-sectional study investigating time burden and costs in the UK.
MacDonald A; Smith TA; de Silva S; Alam V; van Loon JM
Mol Genet Metab Rep; 2016 Dec; 9():1-5. PubMed ID: 27622144
[TBL] [Abstract][Full Text] [Related]
4. Dietary patterns, cost and compliance with low-protein diet of phenylketonuria and other inherited metabolic diseases.
Mlčoch T; Puda R; Ješina P; Lhotáková M; Štěrbová Š; Doležal T
Eur J Clin Nutr; 2018 Jan; 72(1):87-92. PubMed ID: 28656971
[TBL] [Abstract][Full Text] [Related]
5. Insurance Reimbursement for Special Foods and Phenylalanine Levels in Patients With PKU in China.
Wang B; Xia Y; Cheng M; Luo H; Xue L; Gong A; Liu X; Liao G; Song J; Ning K
JAMA Netw Open; 2024 Jun; 7(6):e2412886. PubMed ID: 38837161
[TBL] [Abstract][Full Text] [Related]
6. Financial burden of healthcare for cancer patients with social medical insurance: a multi-centered study in urban China.
Mao W; Tang S; Zhu Y; Xie Z; Chen W
Int J Equity Health; 2017 Oct; 16(1):180. PubMed ID: 29017542
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the impact of phenylketonuria and its treatment on quality of life of patients and parents from seven European countries.
Bosch AM; Burlina A; Cunningham A; Bettiol E; Moreau-Stucker F; Koledova E; Benmedjahed K; Regnault A
Orphanet J Rare Dis; 2015 Jun; 10():80. PubMed ID: 26084935
[TBL] [Abstract][Full Text] [Related]
8. Expenditure and financial burden for the diagnosis and treatment of colorectal cancer in China: a hospital-based, multicenter, cross-sectional survey.
Huang HY; Shi JF; Guo LW; Bai YN; Liao XZ; Liu GX; Mao AY; Ren JS; Sun XJ; Zhu XY; Wang L; Song BB; Du LB; Zhu L; Gong JY; Zhou Q; Liu YQ; Cao R; Mai L; Lan L; Sun XH; Ren Y; Zhou JY; Wang YZ; Qi X; Lou PA; Shi D; Li N; Zhang K; He J; Dai M
Chin J Cancer; 2017 Apr; 36(1):41. PubMed ID: 28454595
[TBL] [Abstract][Full Text] [Related]
9. Financial burden on the families of patients with hepatitis B virus-related liver diseases and the role of public health insurance in Yunnan province of China.
Che YH; Chongsuvivatwong V; Li L; Sriplung H; Wang YY; You J; Ma SJ; Yan Y; Zhang RY; Shen T; Chen HM; Rao SF; Zhang XL
Public Health; 2016 Jan; 130():13-20. PubMed ID: 25931438
[TBL] [Abstract][Full Text] [Related]
10. Health Related Quality of Life assessment among early-treated Hungarian adult PKU patients using the PKU-QOL adult questionnaire.
Barta AG; Sumánszki C; Turgonyi Z; Kiss E; Simon E; Serfőző C; Reismann P
Mol Genet Metab Rep; 2020 Jun; 23():100589. PubMed ID: 32346514
[TBL] [Abstract][Full Text] [Related]
11. Inpatient care burden due to cancers in Anhui, China: a cross-sectional household survey.
Zhao T; Cheng J; Chai J; Feng R; Liang H; Shen X; Sha R; Wang D
BMC Public Health; 2016 Apr; 16():308. PubMed ID: 27067524
[TBL] [Abstract][Full Text] [Related]
12. Phenylketonuria Scientific Review Conference: state of the science and future research needs.
Camp KM; Parisi MA; Acosta PB; Berry GT; Bilder DA; Blau N; Bodamer OA; Brosco JP; Brown CS; Burlina AB; Burton BK; Chang CS; Coates PM; Cunningham AC; Dobrowolski SF; Ferguson JH; Franklin TD; Frazier DM; Grange DK; Greene CL; Groft SC; Harding CO; Howell RR; Huntington KL; Hyatt-Knorr HD; Jevaji IP; Levy HL; Lichter-Konecki U; Lindegren ML; Lloyd-Puryear MA; Matalon K; MacDonald A; McPheeters ML; Mitchell JJ; Mofidi S; Moseley KD; Mueller CM; Mulberg AE; Nerurkar LS; Ogata BN; Pariser AR; Prasad S; Pridjian G; Rasmussen SA; Reddy UM; Rohr FJ; Singh RH; Sirrs SM; Stremer SE; Tagle DA; Thompson SM; Urv TK; Utz JR; van Spronsen F; Vockley J; Waisbren SE; Weglicki LS; White DA; Whitley CB; Wilfond BS; Yannicelli S; Young JM
Mol Genet Metab; 2014 Jun; 112(2):87-122. PubMed ID: 24667081
[TBL] [Abstract][Full Text] [Related]
13. Determinants and Equity Evaluation for Health Expenditure Among Patients with Rare Diseases in China.
Xin XX; Zhao L; Guan XD; Shi LW
Chin Med J (Engl); 2016 Jun; 129(12):1387-93. PubMed ID: 27270531
[TBL] [Abstract][Full Text] [Related]
14. Diet in phenylketonuria: a snapshot of special dietary costs and reimbursement systems in 10 international centers.
Belanger-Quintana A; Dokoupil K; Gokmen-Ozel H; Lammardo AM; MacDonald A; Motzfeldt K; Nowacka M; Robert M; van Rijn M; Ahring K
Mol Genet Metab; 2012 Mar; 105(3):390-4. PubMed ID: 22217429
[TBL] [Abstract][Full Text] [Related]
15. Development and psychometric validation of measures to assess the impact of phenylketonuria and its dietary treatment on patients' and parents' quality of life: the phenylketonuria - quality of life (PKU-QOL) questionnaires.
Regnault A; Burlina A; Cunningham A; Bettiol E; Moreau-Stucker F; Benmedjahed K; Bosch AM
Orphanet J Rare Dis; 2015 May; 10():59. PubMed ID: 25958326
[TBL] [Abstract][Full Text] [Related]
16. Economic burden of gastrointestinal cancer under the protection of the New Rural Cooperative Medical Scheme in a region of rural China with high incidence of oesophageal cancer: cross-sectional survey.
Li X; Cai H; Wang C; Guo C; He Z; Ke Y
Trop Med Int Health; 2016 Jul; 21(7):907-16. PubMed ID: 27125226
[TBL] [Abstract][Full Text] [Related]
17. The financial and time burden associated with phenylketonuria treatment in the United States.
Rose AM; Grosse SD; Garcia SP; Bach J; Kleyn M; Simon NE; Prosser LA
Mol Genet Metab Rep; 2019 Dec; 21():100523. PubMed ID: 31660292
[TBL] [Abstract][Full Text] [Related]
18. Expenditure and Financial Burden for Stomach Cancer Diagnosis and Treatment in China: A Multicenter Study.
Zhang K; Yin J; Huang H; Wang L; Guo L; Shi J; Dai M
Front Public Health; 2020; 8():310. PubMed ID: 32850573
[No Abstract] [Full Text] [Related]
19. Current situation and prospects of newborn screening and treatment for Phenylketonuria in China - compared with the current situation in the United States, UK and Japan.
Mei L; Song P; Kokudo N; Xu L; Tang W
Intractable Rare Dis Res; 2013 Nov; 2(4):106-14. PubMed ID: 25343113
[TBL] [Abstract][Full Text] [Related]
20. The challenges of managing coexistent disorders with phenylketonuria: 30 cases.
MacDonald A; Ahring K; Almeida MF; Belanger-Quintana A; Blau N; Burlina A; Cleary M; Coskum T; Dokoupil K; Evans S; Feillet F; Giżewska M; Gokmen Ozel H; Lotz-Havla AS; Kamieńska E; Maillot F; Lammardo AM; Muntau AC; Puchwein-Schwepcke A; Robert M; Rocha JC; Santra S; Skeath R; Strączek K; Trefz FK; van Dam E; van Rijn M; van Spronsen F; Vijay S
Mol Genet Metab; 2015 Dec; 116(4):242-51. PubMed ID: 26498184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
